First Time Loading...

Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 29.78 USD -2.36% Market Closed
Updated: May 20, 2024

Arcturus Therapeutics Holdings Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arcturus Therapeutics Holdings Inc
Current Portion of Long-Term Debt Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Current Portion of Long-Term Debt
$10.2B
CAGR 3-Years
-3%
CAGR 5-Years
45%
CAGR 10-Years
88%
Gilead Sciences Inc
NASDAQ:GILD
Current Portion of Long-Term Debt
$3.7B
CAGR 3-Years
18%
CAGR 5-Years
8%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Current Portion of Long-Term Debt
$4B
CAGR 3-Years
37%
CAGR 5-Years
1%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also